The protein expression of Nrf2, HO-1, and NQO1, which are phase 2 antioxidant enzymes, significantly (p < 0.001) decreased in DSS-induced colitis, and was significantly (p < 0.05) increased by OJE administration. The gene discussed is NQO1; the disease is colitis.